Allogeneic versus autologous bone marrow transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase III trial (AML8 A). The EORTC Leukemia Cooperative Group and the GIMEMA Group.
Zittoun
R
R
Service d'Hématologie, Hotel Dieu, Paris, France.
Mandelli
F
F
Willemze
R
R
de Witte
T
T
Tura
S
S
Ferrini
P R
PR
Stryckmans
P
P
Gattringer
C
C
Petti
M C
MC
Solbu
G
G
D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D002648:Child; D002985:Clinical Protocols; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery*; D008875:Middle Aged; D012074:Remission Induction; D016019:Survival Analysis; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous
D003561:Cytarabine; D003630:Daunorubicin